Early trial data offers fresh hope for the most vulnerable to COVID-19. Phase one and two results indicate high-risk groups could build strong immunity, new research reveals.
The findings, published in The Lancet medical journal, suggest a major breakthrough in protecting those most at risk of severe illness or death from the virus.
We are your go-to destination for breaking UK news, real-life stories from communities across the country, striking images, and must-see video from the heart of the action.
Follow us on Facebook at for the latest updates and developing stories, and stay connected on X (Twitter) the for live coverage as news breaks across the UK.
SIGN UP NOW FOR YOUR FREE DAILY BREAKING NEWS AND PICTURES NEWSLETTER
Your information will be used in accordance with our Privacy Policy
